Weight Loss Surgery vs GLP-1 Injections: Which Lasts Longer?

For anyone considering medical weight loss, two options often come up: weight loss surgery such as gastric sleeve or bypass, and GLP-1 injections like Wegovy or Mounjaro. Both approaches can help patients lose weight, but how do they compare in the long run?

At Transform, we’ve seen thousands of patients succeed through surgery, and we also keep a close eye on emerging medical treatments. This guide compares the two, looking at safety, sustainability, and patient experiences.

What Are GLP-1 Injections?

GLP-1 receptor agonists (such as semaglutide or Tirzepatide) are medications originally developed for type 2 diabetes. They work by mimicking the hormone GLP-1, slowing stomach emptying to help you feel fuller for longer, and reducing food cravings.

In 2023, NICE approved semaglutide (Wegovy) for NHS weight management in certain patients (NICE guidance).

While effective, GLP-1 treatments usually require ongoing weekly injections, and weight regain is common once treatment stops.

What Is Weight Loss Surgery?

Weight loss surgery, also called bariatric surgery, includes procedures such as:

  • Gastric sleeve – reducing stomach size by around 70–80%
  • Gastric bypass – Reducing stomach size and re – routing intestines to reduce absorption
  • Gastric band – a silicon ring around the stomach helps to manage hunger and portion sizes

These procedures help to restrict food  intake and, in some cases, alter how food is absorbed. According to the American Society for Metabolic and Bariatric Surgery, surgery results in average weight loss of 25–35% of body weight maintained for many years (ASMBS data).

Short-Term Results: GLP-1 vs Surgery

GLP-1 injections such as Wegovy can help patients lose 10–15% of body weight over 1–2 years, according to clinical trials published in The New England Journal of Medicine.

Weight loss surgery can give up to 70% excess weight loss depending on the procedure. The majority is lost on the first 18 months post – procedure

Key takeaway: Both are effective in the short term, but surgery offers a higher average weight loss and a longer term solution.

Long-Term Results: Which Lasts Longer?

The main difference lies in sustainability.

GLP-1 treatments work only while injections continue. Studies show that patients may regain two-thirds of the weight lost within a year of discontinuation (Rubino et al., 2021, Diabetes Care).

By contrast, decades of data show bariatric surgery provides longer term weight loss, with patients maintaining significant reductions even after 10–20 years (NHS UK – Bariatric Surgery).

Take Pat Conder’s story:

“At 4ft 10 inches and weighing in at 14st 7lb, it’s easy to see that I had to make some changes… I could never dream I would come as far as I have today. All the wonderful help and support I’ve received from dieticians, and my nurse Nikki has helped me along the way.”

Impact on Health Beyond Weight Loss

Both GLP-1 medications and surgery improve health, but the extent varies.

GLP-1 injections are effective for managing type 2 diabetes and reducing cardiovascular risk, but only while treatment continues.

Weight loss surgery has been shown to send type 2 diabetes into remission in many cases and reduce the risk of heart disease, sleep apnoea, and certain cancers. NHS research confirms many patients experience long-term remission of obesity-related conditions.

Patient Experience: Real Stories

At Transform, we’ve seen how surgery transforms lives.

Pat Conder, who had weight loss surgery, says:

“At 4ft 10 inches and weighing in at 14st 7lb it’s easy to see that I had to make some changes. As I started out on my journey back in July 2015 I could never dream I would come as far as I have today. All the wonderful help and support I have received from the dieticians and Nikki, my favourite nurse, has helped me come a long way.”

Heidi’s journey:

“Great level of customer service and care… from Sally, my dietician, pre-op nurse and Dr John Robinson, the whole team have been excellent. They’ve been the start of my journey to getting healthy with my weight loss.”

Lynsey McCullough:

“I had a gastric band fitted 2 years ago… I started off at nearly 17 stone but now weigh 9 stone 9 lbs. Nicola was there for me every step of the way — I would highly recommend her to anyone.”

These experiences reflect clinical evidence: surgery provides not only  excellent  weight loss but also durability and freedom from constant medication.

Risks and Considerations

GLP-1 injections can cause nausea, diarrhoea, and long-term safety beyond 5–10 years is still being studied.

Bariatric surgery like any surgery carries operative risks such as bleeding or infection, but is considered safe in experienced hands, especially in CQC-regulated hospitals with specialist bariatric surgeons.

Every patient should undergo a thorough consultation and health screening before deciding.

Costs and Commitment

GLP-1 treatments require ongoing monthly costs, and stopping usually leads to weight regain.

Surgery involves a higher upfront cost but is usually more cost-effective in the long term, as results can last long term without the need for continuous medication.

Which Lasts Longer?

GLP-1 injections can deliver meaningful weight loss, but results usually depend on long-term use.

Weight loss surgery offers durable, long-term results with extensive evidence across decades.

For patients seeking a permanent solution, surgery is still the gold standard in terms of a weight loss solution. For those looking for a less invasive but short-term option, GLP-1 treatments may be appropriate.

Final Thoughts

The choice between weight loss surgery and GLP-1 injections are personal. What’s clear is that surgery delivers greater and longer-lasting results, GLP-1 injections are effective but  usually only while continued, and both should be supported with lifestyle changes and medical supervision.

At Transform, our role is to help patients make the right decision for their goals, health, and long-term wellbeing.

Medically reviewed by Sue Norton, Head of Weight Management

Clinical Dietetics Team for Transform Weight Loss

Last Reviewed September 4th 2025

Frequently Asked Questions About Weight Loss Surgery and GLP-1 Injections

Can GLP-1 injections replace weight loss surgery?

GLP-1 medications such as Wegovy or Mounjaro can help patients lose weight, but they are not considered a replacement for surgery. Injections work while you continue treatment, whereas surgery provides a more permanent anatomical change that supports long-term weight loss.

Most patients maintain weight loss while on treatment, but studies show that stopping GLP-1 injections often leads to regaining much of the weight within a year. This is because appetite and metabolism return to pre-treatment levels once the medication is discontinued.

Yes. Bariatric surgery creates long-lasting changes to the stomach and digestive system. Patients can typically maintain significant weight loss long term when combined with lifestyle changes.

Both are considered safe when monitored by healthcare professionals. GLP-1 injections may cause nausea or digestive side effects, while surgery carries operative risks such as bleeding or infection. However, surgery is performed in CQC-regulated hospitals by GMC-registered bariatric surgeons, ensuring the highest levels of safety.

This depends on the type of procedure you are having and your chosen provider. An individual assessment can check your eligibility.  According to NHS guidance, surgery is usually considered for patients with:

  • A BMI of 40 or more, or  
  • A BMI of 35-40 with obesity-related conditions such as type 2 diabetes.
    Eligibility also depends on previous weight loss attempts and overall health.

Yes,  patients are required to take vitamin tablets long term.  Your bariatric care team will guide you on this.